Form S-1/A IN8BIO, INC.

Go back to Form S-1/A IN8BIO, INC.

IN8bio, Inc (INAB) Files For up to $46M IPO

July 20, 2021 6:19 AM EDT

IN8bio, Inc (NASDAQ: INAB) has fled for up to $46,000,000 IPO.

The company describes itself as: "We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are... More